Medium materiality6/10
ImmunityBio price target raised to $14 from $12 at Jefferies
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raises ImmunityBio price target to $14 from $12; posted price is $9.91.
- Jefferies raises IBRX PT to $14 from $12; current price $9.91.
Key facts
- 01
Target: $14
- 02
Posted price: $9.91
- 03
Analyst firm: Jefferies
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.